Faecal
Microbiota
Transplant
Restoring Gut Health
with Precision:
The Power of FMT
At AMILI, we offer cutting-edge Faecal Microbiota Transplant (FMT) therapy, a proven treatment for gut health restoration. Using healthy microbiome material from a carefully selected donor, our FMT service is trusted by healthcare professionals to effectively treat conditions such as
Clostridioides difficile
infection (CDI)
and explore new frontiers in gut health, including potential applications for
Inflammatory Bowel Disease (IBD)
, and other emerging conditions.
Why
Faecal Microbiota Transplant (FMT)?
FMT is an innovative treatment that has shown substantial success in replenishing a patient’s gut microbiota with healthy, balanced bacterial populations. It's especially beneficial when conventional treatments fail, restoring gut microbiome diversity, and helping to overcome chronic conditions like C. difficile infection and IBD. Dr. David Ong, one of AMILI’s cofounders, administered the first FMT in Singapore in 2020, using FMT from our bank.
Proven Clinical Success
Our
FMT
Service
AMILI is a pioneer in the Southeast Asian region, providing FMT preparations to hospitals and clinics since 2020. We are proud to offer the region’s first stool bank for FMTs, ensuring high-quality, safe, and effective donor microbiota.
Key Features:
High-Quality Stool Bank
Our stool samples come from a meticulously curated, healthy donor pool, ensuring optimal outcomes for patients.
Clinical Oversight
Our FMT procedures are administered by qualified healthcare professionals, with strict clinical guidelines to ensure patient safety and effectiveness.
Region-Exclusive Offering
AMILI is the only provider of FMT in Southeast Asia with a robust infrastructure for stool sourcing and microbiome treatments
Our
Faecal Mictobiota Transplant (FMT)
Capsules
Oral capsules containing FMT preparations are ingested and are designed to break down in the gut, ensuring that the healthy bacteria reach the appropriate area. AMILI is working on developing smaller capsules for more accessible oral formulation for future availability.
Partnering
with AMILI for FMT Solutions
As a healthcare provider, you can trust AMILI’s FMT service for your patients’ gut health needs. We aim to support you with the latest scientific advancements and high-quality solutions that can improve patient outcomes.
Reliable Results
With a high success rate in treating
C. difficile
infections, AMILI’s FMT offers a proven solution for challenging gut health cases.
Scientific Expertise
AMILI has been at the forefront of microbiome research, partnering with leading institutions such as A*STAR, NUS, and NUH.
Comprehensive Support
From donor screening to clinical administration, AMILI provides end-to-end support for healthcare providers looking to incorporate FMT into their practice.
FMT
Donor Program
At AMILI, we also run an FMT Donor Program, ensuring that the stool samples used for transplants come from healthy, high-quality donors. If you’re interested in being a donor, or referring patients for FMT, this program guarantees that all donor stool is thoroughly screened and meets the stringent health criteria required for medical use.
Donor Screening
Candidates undergo a thorough health assessment to ensure they meet the stringent criteria for becoming an FMT donor.
Health & Safety
Each donation is screened for pathogens and contaminants to guarantee safety for patients undergoing FMT.
Life-Saving Contribution
Donors play an essential role in the treatment of patients with severe gut conditions, making a tangible impact on patient recovery.
Emerging Indications
for FMT
In addition to treating C. difficile infections, AMILI is investigating the potential of FMT for several other conditions, including:
Inflammatory Bowel Disease (IBD):
Early studies suggest that restoring gut microbiome balance can help manage chronic conditions like IBD.
Chronic Conditions:
FMT may help in managing other chronic diseases linked to gut dysbiosis, such as metabolic disorders and obesity.
Chronic Kidney Disease:
Studies, and prior FMT usage by AMILI suggest FMT helps manage CKD by addressing gut dysbiosis and improving the gut-kidney axis.
Neurological Health:
Emerging research points to the gut-brain connection, with potential benefits for conditions like autism, depression, and anxiety.
Oncology and Immunocompromisation:
Our research shows significant benefit in FMT for supportive health in oncology, as well as immunocompromisation in general. Restoration of the gut microbiome is linked to better health outcomes for cancer patients.
Interested in learning more?
Would you like to explore how FMT can benefit your patients or learn more about becoming a partner with AMILI? Get in touch with us today, and our team will provide the necessary support and information to help you integrate this advanced therapy into your clinical practice.
Advancing Human Health Through Microbiome Science
.svg)